Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ben-Menachem

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Advances in Neurology|December 28, 1999
The role of new antiepileptic drugsE Ben-Menachem
Epilepsia|January 1, 1997
Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experienceE Ben-Menachem
Epilepsia|January 1, 1995
VigabatrinE Ben-Menachem
Epilepsia|January 1, 1996
Expanding antiepileptic drug options: clinical efficacy of new therapeutic agentsE Ben-Menachem
Current Opinion in Neurology|September 15, 2000
New antiepileptic drugs and non-pharmacological treatmentsE Ben-Menachem
Acta Neurologica Scandinavica. Supplementum|March 14, 2013
This supplement provides an overview of the development of perampanel, the first non-competitive AMPA-type glutamate receptor antagonist to be developed as an adjunctive treatment for refractory partial-onset seizures. IntroductionE Ben-Menachem
Anaesthesia and Intensive Care|March 10, 2018
The effect of a multifaceted postoperative nausea and vomiting reduction strategy on prophylaxis administration amongst higher-risk adult surgical patientsA Pym, E Ben-Menachem
Epilepsia|October 29, 2000
Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study GroupE Ben-Menachem, U Falter
Epilepsy Research|February 26, 1998
Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patientsM Kyllerman, E Ben-Menachem
Acta Neurologica Scandinavica. Supplementum|September 27, 2003
Epilepsy and comorbidity: a global approach to patient managementE Ben-Menachem, A Covanis
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Advances in Neurology|December 28, 1999
The role of new antiepileptic drugsE Ben-Menachem
Epilepsia|January 1, 1997
Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experienceE Ben-Menachem
Epilepsia|January 1, 1995
VigabatrinE Ben-Menachem
Epilepsia|January 1, 1996
Expanding antiepileptic drug options: clinical efficacy of new therapeutic agentsE Ben-Menachem
Current Opinion in Neurology|September 15, 2000
New antiepileptic drugs and non-pharmacological treatmentsE Ben-Menachem
Acta Neurologica Scandinavica. Supplementum|March 14, 2013
This supplement provides an overview of the development of perampanel, the first non-competitive AMPA-type glutamate receptor antagonist to be developed as an adjunctive treatment for refractory partial-onset seizures. IntroductionE Ben-Menachem
Anaesthesia and Intensive Care|March 10, 2018
The effect of a multifaceted postoperative nausea and vomiting reduction strategy on prophylaxis administration amongst higher-risk adult surgical patientsA Pym, E Ben-Menachem
Epilepsia|October 29, 2000
Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study GroupE Ben-Menachem, U Falter
Epilepsy Research|February 26, 1998
Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patientsM Kyllerman, E Ben-Menachem
Acta Neurologica Scandinavica. Supplementum|September 27, 2003
Epilepsy and comorbidity: a global approach to patient managementE Ben-Menachem, A Covanis
Pageof 7